These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 3728336

  • 1. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 2. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 8. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 9. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 10. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate.
    Bexton RS, Hellestrand KJ, Nathan AW, Spurrell RA, Camm AJ.
    Eur Heart J; 1983 Feb 25; 4(2):92-102. PubMed ID: 6852073
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC.
    J Am Coll Cardiol; 1990 Dec 25; 16(7):1649-55. PubMed ID: 2123908
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Dec 25; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 15. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ, Hellestrand KJ, Nathan AW, Bexton RS.
    Drugs; 1985 Dec 25; 29 Suppl 4():7-13. PubMed ID: 4006783
    [Abstract] [Full Text] [Related]

  • 16. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun 25; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT, Campbell RW, McComb JM.
    J Cardiovasc Pharmacol; 1991 Feb 25; 17(2):310-5. PubMed ID: 1709237
    [Abstract] [Full Text] [Related]

  • 18. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
    Chazov EI, Rosenshtraukh LV, Shugushev KK.
    Am Heart J; 1984 Sep 25; 108(3 Pt 1):483-9. PubMed ID: 6382989
    [Abstract] [Full Text] [Related]

  • 19. Pirmenol in termination of paroxysmal supraventricular tachycardia.
    Toivonen LK.
    Clin Cardiol; 1986 Aug 25; 9(8):369-73. PubMed ID: 3731562
    [Abstract] [Full Text] [Related]

  • 20. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Aug 25; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.